Does Adherence to Medications for Type 2 Diabetes Differ Between Individuals With Vs Without Schizophrenia?Julie Kreyenbuhl, M. Valenstein, Sohail Soliman et al.|Schizophrenia Bulletin|2008Cited by 101
Long-Term Antipsychotic Polypharmacy in the VA Health System: Patient Characteristics and Treatment PatternsJulie Kreyenbuhl, Frederic C. Blow, John F. McCarthy et al.|Psychiatric Services|2007Cited by 99
Long-term combination antipsychotic treatment in VA patients with schizophreniaJulie Kreyenbuhl, Frederic C. Blow, Marcia Valenstein et al.|Schizophrenia Research|2006Cited by 85